《Lancet,3月25日,Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-26
  • Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak

    Fabiana Zingone,Edoardo Vincenzo Savarino

    Published:March 25, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30085-6

    We read with interest the Comment by Ren Mao and colleagues on the implications of coronavirus disease 2019 (COVID-19) in patients with pre-existing digestive diseases, and the strategies implemented in China to restrict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with inflammatory bowel disease.1

    We agree with the current evidence that does not support drug suspension and also with the European Crohn's and Colitis Organisation COVID-19 Task Force's suggestion that, whenever possible during the COVID-19 pandemic, initiation of treatment with immunosuppressive drugs and biologics should be postponed based on an individual risk assessment.2 However, for patients with substantial clinical activity, delaying the initiation of treatment might not always be possible.

  • 原文来源:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30085-6/fulltext
相关报告
  • 《LANCET,3月23日,COVID-19 and medical education》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • COVID-19 and medical education Hanad Ahmed Mohammed Allaf Hussein Elghazaly Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30226-7 The coronavirus disease 2019 (COVID-19) outbreak has rapidly transitioned into a worldwide pandemic. This development has had serious implications for public institutions and raises particular questions for medical schools. Frequent rotations between departments and hospitals make medical students potential vectors for COVID-19. Equally, as trainee doctors we stand to learn a tremendous amount and can contribute to the care of patients, particularly if the UK General Medical Council triggers article 18a of the Medical Student Act (1983).
  • 《LANCET,3月20日,COVID-19 outbreak: less stethoscope, more ultrasound》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-21
    • COVID-19 outbreak: less stethoscope, more ultrasound Danilo Buonsenso Davide Pata Antonio Chiaretti Published:March 20, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30120-X In their Correspondence in The Lancet Respiratory Medicine, Jonathan Cheung and colleagues stressed the need to ensure staff safety in the airway management of patients with 2019 novel coronavirus disease (COVID-19).1 This safety should be guaranteed from the patient's first assessment. In fact, maintaining the safety of the doctor, who meets many people during his daily activity, avoids the spread of the disease to other patients and the possible creation of new epidemic outbreaks. However, patients with fever and respiratory symptoms do still need to be seen. The standard method involves doing an objective examination and carrying out any radiological tests, such as chest radiography or chest CT.